Ansbro E, Masri S, Prieto-Merino D, Bahous SA, Molfino L, et al.
2022-05-11 • MSF Scientific Days International 2022
2022-05-11 • MSF Scientific Days International 2022
INTRODUCTION Cardiovascular disease (CVD) is the leading cause of death and disability globally, including in humanitarian contexts. Fixed-dose combination (FDC) drugs are cost-effec...
Mohamad M, Moussally K, Lakis C, El-Hajj M, Bahous SA, et al.
2021-05-10 • PLOS One
2021-05-10 • PLOS One
INTRODUCTION Low adherence to medications, specifically in patients with Diabetes (DM) and Hypertension (HTN), and more so in refugee settings, remains a major challenge to achieving...
Murphy A, Willis R, Ansbro É, Masri S, Kabbara N, et al.
2022-06-04 • BMC Health Services Research
2022-06-04 • BMC Health Services Research
BACKGROUND We report findings of a qualitative evaluation of fixed-dose combination therapy for patients with established atherosclerotic cardiovascular disease (ASCVD) attending Méd...
